Early osteoarthritis – current state of the art

Osteoarthritis (OA) is increasingly recognized as a complex degenerative joint disease that develops under the influence of mechanical, biochemical and genetic factors. The pathogenesis of OA includes a complex of interactions at both cellular and molecular levels, leading to progressive damage to joint tissues – cartilage degeneration, synovial inflammation, remodeling of the subchondral bone, and periarticular changes. In the last decade, the term “early osteoarthritis” has been increasingly mentioned in the scientific literature. The concept of early OA was largely determined by the experience of rheumatoid arthritis treatment. Given the heterogeneity of OA, pathological processes at the cellular and molecular levels, reflecting the early stage of the disease, are diverse and depend on the factors that induce the disease. Symptoms of early OA of the knee joint can be suspected with the appearance of intermittent pain or discomfort in the joint, short-term “initial” stiffness and functional limitations. Clinical examination in most cases reveals pain on palpation of the joint, crepitation or moderate articular effusion. X-ray data are of limited importance at an early stage of the disease, since one of the typical signs of OA – narrowing of the articular gap – may not appear for many years. Quantitative, contrast-enhanced magnetic resonance imaging methods, as well as hybrid methods are used to visualize OA at an early stage. The final goals of developing classification criteria for early OA and early diagnosis of the disease in real clinical practice differ. Early OA represents a “window of opportunity” to prevent disease progression before OA becomes clinically apparent. It is necessary to continue research on the definition and classification of early OA of other localizations. Pharmacological innovations, regenerative methods, and gene therapy represent the future of OA treatment, including at an early stage of the disease. One of the modern drugs that modify the course of OA is Elmosa, a unique combination of glucosamine sulfate, boswellic acids combined with acetyl-L-carnitine and B vitamins.

1. GBD 2019 MSK in Adolescents Collaborators. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050. Med 2024;5(8):943–62.e6. DOI: 10.1016/j.medj.2024.04.009

2. Zhao W., Long Y., Wang Y., Chin K.Y. Osteoarthritis: an integrative overview from pathogenesis to management. Malays J Pathol 2024;46(3):369–78. PMID: 39731486.

3. Grässel S., Aszodi A. Osteoarthritis and cartilage regeneration: focus on pathophysiology and molecular mechanisms. Int J Mol Sci 2019;20(24):6156. DOI: 10.3390/ijms20246156

4. Lee A.S., Ellman M.B., Yan D. et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013;527(2):440–7. DOI: 10.1016/j.gene.2013.05.069

5. Deveza L.A., Loeser R.F. Is osteoarthritis one disease or a collection of many? Rheumatology (Oxford) 2018;57(suppl_4):iv34–42. DOI: 10.1093/rheumatology/kex417

6. Raman S., FitzGerald U., Murphy J.M. Interplay of inflammatory mediators with epigenetics and cartilage modifications in osteoarthritis. Front Bioeng Biotechnol 2018;6:22. DOI: 10.3389/fbioe.2018.00022

7. Weber A.E., Bolia I.K., Trasolini N.A. Biological strategies for osteoarthritis: from early diagnosis to treatment. Int Orthop 2021;45(2):335–44. DOI: 10.1007/s00264-020-04838-w

8. Im G.I. The concept of early osteoarthritis and its significance in regenerative medicine. Tissue Eng Regen Med 2022;19(3):431–6. DOI: 10.1007/s13770-022-00436-6

9. Kellgren J.H., Lawrence J.S. Radiological assessment Lection of osteo-arthrosis. Ann Rheum Dis 1957;16(4):494–502. DOI: 10.1136/ard.16.4.494

10. Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29(8):1039–49. DOI: 10.1002/art.1780290816

11. Migliore A., Alekseeva L., Avasthi S.R. et al. Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage. Ther Adv Musculoskelet Dis 2023;15:1759720X221131604. DOI: 10.1007/s40265-022-01773-5

12. Mahmoudian A., Lohmander L.S., Mobasheri A. et al. Early-stage symptomatic osteoarthritis of the knee – time for action. Nat Rev Rheumatol 2021;17(10):621–32. DOI: 10.1038/s41584-021-00673-4

13. Madry H., Kon E., Condello V. et al. Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 2016;24(6):1753–62. DOI: 10.1007/s00167-016-4068-3

14. Hayashi D., Roemer F.W. et al. Imaging in Osteoarthritis. Radiol Clin North Am 2017;55(5):1085–102. DOI: 10.1016/j.rcl.2017.04.012

15. Luyten F.P., Denti M., Filardo G. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 2012;20(3):401–6. DOI: 10.1007/s00167-011-1743-2

16. Migliore A., Scirè C.A., Carmona L. et al. The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology. Rheumatol Int 2017;37(8):1227–36. DOI: 10.1007/s00296-017-3700-y Erratum in: Rheumatol Int 2017;37(8):1237–8. DOI: 10.1007/s00296-017-3742-1

17. Luyten F.P., Bierma-Zeinstra S., Dell’Accio F. Toward classification criteria for early osteoarthritis of the knee. Semin Arthritis Rheum 2018;47(4):457–63. DOI: 10.1016/j.semarthrit.2017.08.006

18. Aggarwal R., Ringold S., Khanna D. et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015;67(7):891–7. DOI: 10.1002/acr.22583

19. Runhaar J., Kloppenburg M., Boers M. et al. Towards developing diagnostic criteria for early knee osteoarthritis: data from the CHECK study. Rheumatology (Oxford) 2021;60(5):2448–55. DOI: 10.1093/rheumatology/keaa643

20. Van Spil W.E., Welsing P.M., Bierma-Zeinstra S.M. et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis Cartilage 2015;23(8):1388–97. DOI: 10.1016/j.joca.2015.03.023

21. Lohmander L.S., Englund P.M., Dahl L.L., Roos E.M. The longterm consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med 2007;35(10):1756–69. DOI: 10.1177/0363546507307396

22. Nasnikova I.Yu., Morozov S.P., Filisteev P.A. Magnetic resonance tomography: quantitative assessment methods in articular cartilage structure analysis of in patients with osteoartrosis. Rossiyskiy zhurnal luchevoy diagnostiki = Russian Electronic Journal of Radiology 2011;1(3):75–82. (In Russ.).

23. Kogan F., Fan A.P., McWalter E.J. et al. PET/MRI of metabolic activity in osteoarthritis: a feasibility study. J Magn Reson Imaging 2017;45(6):1736–45. DOI: 10.1002/jmri.25529

24. Pravdyuk N.G., Shostak N.A., Novikova A.V., Klimenko A.A. Back pain. Clinician’s Handbook, 5th ed., rev. and add. Ed.: N.A. Shostak. Moscow: ABV-press, 2024. (In Russ.).